Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luck Lukusa
Observed names:
L Lukusa,
L. Lukusa
Institution:
Research Institute of the McGill University Health Centre
Observed institutions:
McGill University Health Centre,
Research Institute of the McGill University Health Centre,
McGill University
ORCID:
0009-0003-6435-8140
Observed ORCID:
0009-0003-6435-8140
OpenAlex ID:
A5088390249
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
2022
·
Celline C Almeida-Brasil
, John G Hanly
, et al.
·
Lupus Science & Medicine
·
23
PDF
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis
2022
·
Thaisa Cotton
, Marvin J Fritzler
, et al.
·
Lupus
·
14
Marital status and age of systemic lupus erythematous diagnosis: the potential for differences related to sex and gender
2019
·
Eugene Brailovski
, Evelyne Vinet
, et al.
·
Lupus Science & Medicine
·
12
PDF
Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus
2021
·
Ariane Barbacki
, Nour Rached-d'Astous
, et al.
·
JCR Journal of Clinical Rheumatology
·
10
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study
2024
·
Dawn M.E. Bowdish
, Vinod Chandran
, et al.
·
The Journal of Rheumatology
·
8
PDF
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
2024
·
Carol A Hitchon
, Dawn M. E. Bowdish
, et al.
·
Vaccines
·
5
PDF
Treatment patterns and control of hypertension in systemic lupus erythematosus (SLE): a cross-sectional study
2021
·
Jia Li Liu
, Christian A Pineau
, et al.
·
BMJ Open
·
5
PDF
Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars
2026
·
Cristiano S Moura
, Albert Etingin
, et al.
·
World Journal of Gastroenterology
·
3
Determinants of Positive Evolution of Symptoms in Children with Autism Spectrum Disorders (ASD) during the COVID-19 Lockdown in the Democratic Republic of Congo. (DRC)
2024
·
Davin Mbeya Mpaka
, Luck Lukusa
, et al.
·
Journal of Autism and Developmental Disorders
·
3
PDF
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study
2024
·
Olga Tsyruk
, Gilaad G. Kaplan
, et al.
·
Vaccines
·
3
PDF
Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus
2026
·
Rima Kaddoura
, Sasha Bernatsky
, et al.
·
Journal of Clinical Epidemiology
·
1
Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis
2025
·
Marina G. Birck
, Jessica Boivin
, et al.
·
Arthritis Research & Therapy
·
1
PDF
Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data
2024
·
Marina G. Birck
, Luck Lukusa
, et al.
·
BMC Rheumatology
·
1
PDF
Use and Perceived Accuracy of Artificial Intelligence (ChatGPT) for Self-Leaning in Inflammatory Arthritis: Opportunities for Equitable Access to Appropriate Information?
2026
·
Magnus Rauch
, Aurélie Marfaing
, et al.
·
The Journal of Rheumatology
Confidence in Arthritis Self-Management Correlates Positively with Prior Access to Educational Resources and Negatively with Financial and Access Barriers
2026
·
Aurélie Marfaing
, Christian Lobaugh
, et al.
·
The Journal of Rheumatology
Tu1591 ADVERSE EVENTS AND INFECTION RISK IN INFLAMMATORY BOWEL DISEASE AFTER INITIATING BIOSIMILAR/ORIGINATOR INFLIXIMAB
2026
·
Cristiano S. Moura
, Claudie Berger
, et al.
·
Gastroenterology
Tu1591 ADVERSE EVENTS AND INFECTION RISK IN INFLAMMATORY BOWEL DISEASE AFTER INITIATING BIOSIMILAR/ORIGINATOR INFLIXIMAB
2026
·
Cristiano S. Moura
, Claudie Berger
, et al.
·
Gastrointestinal Endoscopy
P0879 Adverse events and infection risk in Inflammatory Bowel Disease after initiating biosimilars/originator infliximab
2026
·
C S Moura
, C Berger
, et al.
·
Journal of Crohn s and Colitis
Drug Discontinuation and Persistent Symptoms Among Initiators of Bio-Originator and Biosimilar Anti–tumor Necrosis Factor Drugs in Inflammatory Bowel Disease: Real-world Contemporary Data From the CAnadian Network for Advanced Interdisciplinary Methods/CIRC Registry
2025
·
Banke Oketola
, Sasha Bernatsky
, et al.
·
Gastro Hep Advances
PDF
Pos1178 Drug Discontinuation in Inflammatory Arthritis Following Mandatory Non-medical Switching From Originator to Biosimilar in Quebec, Canada
2025
·
C.S. Moura
, L. Lukusa
, et al.
·
Annals of the Rheumatic Diseases
Interval-censored Outcomes and Flare Risk After Hydroxychloroquine Tapering/cessation: Sensitivity Analyses of Systemic Lupus International Collaborating Clinics (slicc) Inception Cohort Data
2025
·
Rima Kaddoura
, Celline Almeida-Brasil
, et al.
·
The Journal of Rheumatology
P1129 Comparison of discontinuation/switching between adalimumab biosimilar and originator in Inflammatory Bowel Disease patients: Preliminary data from CAN-AIM
2025
·
L Lukusa
, M G Birck
, et al.
·
Journal of Crohn s and Colitis
Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study
2024
·
Rami Habib
, Roya M. Dayam
, et al.
·
ACR Open Rheumatology
A252 Drug Discontinuation and Persistent Symptoms Among the Users of Biosimilar and Legacy Anti-tnf Drugs in a Real-world Canadian Ibd Cohort
2024
·
B Oketola
, L Lukusa
, et al.
·
Journal of the Canadian Association of Gastroenterology
PDF
P672 Occurrence of malignancy among infliximab biosimilar and bio-originator initiators in Canada: a comparative population-based analysis
2024
·
M G Birck
, L Lukusa
, et al.
·
Journal of Crohn s and Colitis
PDF
Show more works
View as search
Works count:
29
Citation count:
89
H-index:
5
I10-index:
4
Year
Topic
Type